Researchers have found that kidney transplant patients who were treated with sirolimus, an anti-rejection drug, may face an increased risk of diabetes. "We demonstrated a robust association between sirolimus and diabetes after transplantation in a large group of kidney transplant recipients in the United States," said a researcher.

Full Story:
HealthDay News

Related Summaries